Liverpool-based Redx Pharma secures ‘transformational’ deal with drugs giant AstraZeneca
Liverpool biotech firm Redx Pharma has signed a “transformational” multi-million pound deal with global pharmaceutical giant AstraZeneca to develop new drugs that will stop...
CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products
CleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding...
FDA lifts partial clinical hold on OncoMed’s vantictumab cancer drug trials
The US Food and Drug Administration (FDA) has lifted a partial hold on patient enrolments for three Phase Ib clinical trials evaluating OncoMed Pharmaceuticals'...
Novo Nordisk introduces Ryzodeg in Mexico for type 2 diabetes
Denmark-based Novo Nordisk has introduced Ryzodeg (insulin degludec/insulin aspart) in Mexico, which will be used to treat adult patients suffering from type 2 diabetes....
FDA grants QIDP status for Wockhardt anti-infective drug discovery program
Wockhardt Limited has announced a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and...
Novartis’ new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial
Today at the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed that its investigational heart...
Senesco completes patient enrolment in Phase Ib/IIa SNS01-T trial
US-based biotech firm Senesco Technologies has completed patient enrolment in its ongoing Phase Ib/IIa clinical trial of SNS01-T to treat patients with relapsed or...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...